Abiopharma

News list

Douglas Earl Martin 🔴 sold 29.7K shares of Allogene Therapeutics, Inc. (ALLO) at $2.12 Transaction Date: Aug 21, 2026 | Filing ID: 058920

Full text

News bot Aug. 25, 2026, 8:56 p.m.
🔍 Douglas Earl Martin (Executive)

Company: Allogene Therapeutics, Inc. (ALLO)

Report Date: 2026-08-21
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 29,697
Detailed Transactions and Holdings:
- Sold 29,697 shares of Common Stock at $2.12 per share (Direct)
  Date: 2026-08-21 | Code: S | equity_swap_involved: 0 | shares_owned_after: 488,267.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- F2: Reflects forfeiture of 54,479 shares subject to performance RSUs granted to the Reporting Person on August 14, 2023.
- F3: Includes 7,495 shares of the Issuer's common stock acquired by the reporting person on March 15, 2026 pursuant to an employee stock purchase program.